表紙
市場調查報告書

口腔癌的臨床試驗檢討(2020年前半期)

Oral Cavity (Mouth) Cancer Global Clinical Trials Review, H1, 2020

出版商 GlobalData 商品編碼 955970
出版日期 內容資訊 英文
訂單完成後即時交付
價格
口腔癌的臨床試驗檢討(2020年前半期) Oral Cavity (Mouth) Cancer Global Clinical Trials Review, H1, 2020
出版日期: 2020年06月01日內容資訊: 英文
簡介

本報告刊載全球口腔癌的臨床試驗檢討,提供各臨床試驗現狀,臨床試驗階段·贊助商類型·端點現狀·G7/E7的臨床試驗分析,各地區為臨床試驗做出貢獻的國家,參加臨床試驗的主要企業的簡介等資訊。

目錄

目錄

表格的清單

圖的清單

  • 報告指南
  • GlobalData臨床試驗的調查範圍
  • 各地區的臨床試驗
  • 各國臨床試驗與平均登記數
  • 亞太地區:為臨床試驗做出貢獻的主要5個國家
  • 歐洲:為臨床試驗做出貢獻的主要5個國家
  • 北美:為臨床試驗做出貢獻的主要國家
  • 中東和非洲:為臨床試驗做出貢獻的主要5個國家
  • 南美:為臨床試驗做出貢獻的主要5個國家
  • G7各國臨床試驗:口腔癌佔腫瘤學的臨床試驗的比率
  • G7各國各階段的臨床試驗
  • G7各國在各臨床試驗狀態上的的臨床試驗
  • E7各國臨床試驗:口腔癌佔腫瘤學臨床試驗的比例
  • E7各國各階段的臨床試驗
  • 各臨床試驗狀態的在E7各國的臨床試驗
  • 不同階段的臨床試驗
  • 不同階段的進行中的臨床試驗
  • 各臨床試驗狀態的臨床試驗
  • 各端點狀況的臨床試驗
  • 一定期間所募集的實驗對象
  • 各贊助商類型的臨床試驗
  • 主要贊助商
  • 參加口腔癌治療臨床試驗的主要企業
  • 主要的醫藥品
  • 臨床試驗簡介的概述

附錄

  • 簡稱
  • 定義
  • 調查手法
  • 2次調查
  • 關於GlobalData
  • 諮詢方式
  • 免責聲明
  • 來源
目錄
Product Code: GDHC6258CTIDB

GlobalData's clinical trial report, "Oral Cavity (Mouth) Cancer Global Clinical Trials Review, H1, 2020" provides an overview of Oral Cavity (Mouth) Cancer Clinical trials scenario. This report provides top line data relating to the clinical trials onOral Cavity (Mouth) Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to Buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Oral Cavity (Mouth) Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Oral Cavity (Mouth) Cancer to Oncology Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Disclaimer
  • Source

List of Tables

List of Tables

  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials by Region, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Oral Cavity (Mouth) Cancer to Oncology Clinical Trials, G7 Countries (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Oral Cavity (Mouth) Cancer to Oncology Clinical Trials, E7 Countries (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Oral Cavity (Mouth) Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

List of Figures

  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2020*
  • Proportion of Oral Cavity (Mouth) Cancer to Oncology Clinical Trials, G7 Countries (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Oral Cavity (Mouth) Cancer to Oncology Clinical Trials, E7 Countries (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2015-2019
  • Oral Cavity (Mouth) Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Oral Cavity (Mouth) Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*
  • GlobalData Methodology